The "Personalized" Horizon: How 2026 is Tailoring Cells...

adicionou um novo artigo Health

2026-02-13 06:35:28 -

The "Personalized" Horizon: How 2026 is Tailoring Cells to the Individual Patient.

In late 2026, the industry is pivoting toward "Patient-Specific Cell Lines." This year, a radical new class of "Induced Pluripotent Stem Cell" (iPSC) platforms has entered human validation, aiming to create "Personalized Factories" for rare disease treatments. This innovation is a primary driver for the market, as it promises to eliminate the "One-Size-Fits-All" approach to medicine. Using...

0 Comentários 0 Compartilhamentos 116 Visualizações 0 Anterior